Milestone Pharmaceuticals(MIST)
$0.41+0.05 (+13.15%)
MIST
Milestone Pharmaceuticals earnings date
$0.41
At close:+0.05 (+13.15%)
Want to see MIST full AI Analyst Report?
Milestone Pharmaceuticals (MIST) Q2 2023 Earnings Report
830 Followers
MIST Q2 2023 EPS Results
- Actual EPS
- -$0.37
- Consensus EPS
- -$0.39
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- -$0.39
MIST Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- Before Open
- Conference Call
- Thursday, August 10, 2023
MIST Upcoming Earnings
Milestone Pharmaceuticals's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MIST Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.21- | -0.16 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.22-0.18 | -0.12 | -50.00% (-0.06) | |
| Aug 12, 2026 | 2026 (Q2) | -0.20-0.21 | -0.2 | -5.00% (-0.01) | |
| May 13, 2026 | 2026 (Q1) | 0.19-0.20 | -0.31 | 35.48% (+0.11) | |
| Mar 20, 2026 | 2025 (Q4) | -0.16-0.16 | -0.19 | 15.79% (+0.03) | |
| Nov 12, 2025 | 2025 (Q3) | -0.16-0.12 | -0.14 | 14.29% (+0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.18-0.20 | -0.14 | -42.86% (-0.06) | |
| May 14, 2025 | 2025 (Q1) | -0.18-0.31 | -0.21 | -47.62% (-0.10) | |
| Mar 13, 2025 | 2024 (Q4) | -0.16-0.19 | -0.32 | 40.63% (+0.13) | |
| Nov 12, 2024 | 2024 (Q3) | -0.16-0.14 | -0.35 | 60.00% (+0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

